Neointimal hyperplasia is the primary lesion underlying atherosclerosis and restenosis after coronary intervention. We previously described the essential angiogenic function of the adrenomedullin (AM)-receptor activity-modifying protein (RAMP) 2 system. In the present study, we assessed the vasoprotective actions of the endogenous AM-RAMP2 system using a wire-induced vascular injury model. We found that neointima formation and vascular smooth muscle cell proliferation were enhanced in RAMP2 +/2 male mice. The injured vessels from RAMP2 +/2 mice showed greater macrophage infiltration, inflammatory cytokine expression, and oxidative stress than vessels from wild-type mice and less re-endothelialization. After endothelial cell-specific RAMP2 deletion in drug-inducible endothelial cellspecific RAMP2 2/2 (DI-E-RAMP2
Originally identified as a vasodilating peptide isolated from human pheochromocytoma (2) , AM is now known to be widely secreted from various organs and tissues, including ECs, and to be involved in a number of biological functions (3) (4) (5) (6) (7) (8) (9) (10) . The plasma levels of AM are elevated in patients with such cardiovascular diseases as hypertension and congestive heart failure (11, 12) . Evidence has also shown that AM is associated with atherosclerosis. AM production is decreased in the coronary circulation of patients with coronary artery disease (13) , and AM levels in the coronary circulation after stent implantation could be a prognostic indicator for restenosis (14) . In addition, we observed that vascular ECspecific AM-overexpressing mice showed resistance to neointimal hyperplasia and fatty streak formation (15) .
AM is a member of the calcitonin superfamily and acts via a G-protein-coupled seven transmembrane domain receptor (16) , calcitonin receptor-like receptor (CLR). The specificity of CLR for its ligands is determined by three receptor activity-modifying proteins (RAMPs), RAMP1, RAMP2, and RAMP3. We showed that homozygous RAMP2 knockout (RAMP2 2/2 ) mice exhibit an embryonically lethal phenotype with abnormal vascular development that is nearly identical to that of AM 2/2 mice. Thus, deletion of RAMP2 almost entirely reproduces the major phenotypes of AM
2/2
, suggesting RAMP2 is specifically involved in the vascular function of AM (17) . Therefore, we have focused on RAMP2 as an alternative therapeutic target for AM, because it might enable us to modulate the vascular functions of AM. To prove the importance of the vascular AM-RAMP2 system, we established vascular EC-specific RAMP2 conditional knockout mice (E-RAMP2 2/2 ) (18). However, although E-RAMP2 2/2 mice survived longer than RAMP2 2/2 mice, most died of endothelial abnormalities and vascular leakage during the perinatal period. This highlights the importance of endothelial RAMP2 to the vascular AM-RAMP2 system. In the present study, we examined the vasoprotective actions of the endogenous AM-RAMP2 system. Using a wireinduced vascular injury model, we analyzed the effect of RAMP2 deficiency on neointima formation in heterozygous RAMP2 knockout mice (RAMP2 +/2 ). Using drug-inducible endothelial cell-specific RAMP2 2/2 mice (DI-E-RAMP2 2/2 ), we further analyzed the role of the vascular endothelial AM-RAMP2 system. We then tested whether inflammatory cell infiltration and reactive oxygen species (ROS) are involved in the development of neointimal hyperplasia. Also, because bone marrowderived cells reportedly contribute to neointima formation, we tested a bone marrow transplantation (BMT) model using these mice. Finally, we investigated the effects of the AM-RAMP2 system on the proliferation and migration of endothelial progenitor cells (EPCs).
Materials and Methods

Animals
All the animals used were C57BL/6J pure background male mice. RAMP2 +/2 mice had been previously generated by our group (17) . Tamoxifen DI-E-RAMP2 2/2 mice were generated by crossbreeding mice expressing tamoxifen-inducible Crerecombinase (Cre-ERT2) under the control of the vascular endothelial-cadherin promoter with floxed RAMP2 mice. To induce RAMP2 gene deletion in DI-E-RAMP2 2/2 mice, tamoxifen (Sigma-Aldrich, St. Louis, MO) was dissolved in corn oil (Sigma-Aldrich) to a concentration of 10 mg/mL, after which 1.5 mg was intraperitoneally injected into mice daily for 5 days. After 2 weeks of the induction of the gene deletion, the expression of RAMP2 in the endothelial cells (ECs) decreased to less than 30% compared with the baseline level (Supplemental Fig. 1 ). No important differences were found in the serum AM level between control and DI-E-RAMP2 2/2 mice or among the BMT recipient mice (Supplemental Fig. 2 ). We confirmed that the tamoxifentreatment itself did not have an effect on the neointima formation (Supplemental Fig. 3 ). Little toxicity was observed following the injection into wild-type (WT), floxed RAMP2, or Cre-ERT2 mice. The blood pressure was not different between the control and DI-E-RAMP2 2/2 mice (Supplemental Fig. 4 ). The mice were maintained under specific pathogen-free conditions in an environmentally controlled clean room at the Division of Laboratory Animal Research, Department of Life Science, Research Center for Human and Environmental Sciences, Shinshu University. All animal handling procedures were performed in accordance with protocols approved by the ethics committee of the institutional animal care and use committee and National Institutes of Health guidelines (Guide for the Care and Use of Laboratory Animals).
Wire-induced vascular injury
Wire-induced injury of the left femoral artery and sham operation of the right femoral artery (no wire injury) were described previously by Sata et al. (19) . In brief, intraperitoneal injection of 2,2,2-tribromoethanol (240 mg/kg) was used for anesthesia during the operation. A straight spring wire (0.38 mm in diameter) was inserted into the left femoral artery following the protocol described previously (20) . The wire was left in place for 2 minutes to denude and dilate the artery. After removal of the wire, the proximal portion of the arterial branch was ligatured, and blood flow through the femoral artery was restored.
Histological examination and immunohistochemistry
The femoral arteries were excised from each mouse, fixed in 4% paraformaldehyde for 24 to 48 hours and embedded in paraffin, after which the femoral arteries were cut into 4-mmthick sections. The sections were stained with elastica van Gieson (EVG) or used for immunohistochemistry. For immunohistochemical analysis, arterial sections were incubated with rat anti-mouse CD31 (BD Biosciences, Franklin Lakes, NJ), mouse anti-human a-smooth muscle actin (Dako, Glostrup, Denmark), rat anti-mouse F4/80 (Bio-Rad, Hercules, CA), mouse anti-mouse 4-hydroxy-2-nonenal (4HNE; NOF Corporation, Tokyo, Japan), or rabbit anti-mouse p67phox (EMD Millipore, Billerica, MA). The sections were then stained with Alexa Fluor 488-or 568-conjugated anti-rabbit, anti-rat, or anti-mouse secondary antibody (Thermo Fisher Scientific Life Sciences). To immunostain 4HNE, biotin-conjugated secondary antibodies were used. 4 0 ,6-Diamidino-2-phenylindole (Invitrogen, Carlsbad, CA) was used to stain the nuclei. Fluorescence was observed using a fluorescence microscope equipped with the appropriate filter sets (BZ-900; Keyence, Osaka, Japan). The antibodies are listed in Table 1 .
Quantitative real-time reverse transcription polymerase chain reaction analysis Total RNA was extracted from tissues or cells using a PureLink RNA Mini Kit (Thermo Fisher Scientific Life Sciences) and subjected to reverse transcription using a high capacity cDNA reverse transcription kit (Applied Biosystems, Carlsbad, CA). Quantitative real-time reverse transcription polymerase chain reaction (RT-PCR) was performed using an Applied Biosystems 7300 real time PCR system (Applied Biosystems) with SYBR green (Toyobo, Osaka, Japan) or Realtime PCR Master Mix (Toyobo) and TaqMan probe (Medical and Biological Laboratories, Co., Ltd., Nagoya, Japan). The primers and probes used are listed in Tables 2 and 3 . The values were normalized to GAPDH (predeveloped TaqMan assay reagents; Thermo Fisher Scientific Life Sciences). The sample numbers are provided in each figure legend.
Bone marrow transplantation
Whole bone marrow cells were harvested from WT and RAMP2 +/2 mice or from DI-E-RAMP2 2/2 and control mice by flushing their femurs with physiological saline. The red blood cells were then lysed by incubation in ammonium-chloride-potassium buffer (150 mmol/L NH4Cl, 10 mmol/L KHCO3, 0.1 mmol/L EDTA; pH 7.2) for 20 minutes at 0°C, as described previously (21) . The remaining cells were washed three times with phosphatebuffered saline and resuspended in 1 mL of phosphate-buffered saline. Recipient mice (C57BL/6J background; purchased from Charles River Laboratories Japan, Inc., Yokohama, Japan; male, 8 to 9 weeks old) were lethally irradiated with a total X-ray dose of 9 Gy (MBR-155R2; Hitachi, Japan) and injected with ). After 8 weeks, all BMT mice underwent wire-induced vascular injury, as described previously (21) .
Bone marrow-derived EPC culture
Bone marrow-derived EPCs were cultured as described previously (22) . The bone marrow cells were obtained from DI-E-RAMP2 2/2 or control mice. In DI-E-RAMP2 2/2 , RAMP2 gene expression was significantly reduced compared with that in the control mice (Supplemental Fig. 5 ).
Mononuclear cells isolated from bone marrow cells (5310 5 /well) were cultured in 5% fetal bovine serum/endothelial basal medium-2 medium (Lonza, Basel, Switzerland) with supplements (SingleQuots Kit; Lonza) on fibronection-coated 12-well dishes and fibronection-coated cover slips (BD Biosciences). After 28 days in culture, the cells were incubated with acetylated low-density lipoprotein labeled with 1,
0 ,3 0 -tetramethylindo-carbocyanine perchlorate (DiI-Ac-LDL; Thermo Fisher Scientific) for 5 hours and then stained with fluorescein isothiocyanate-conjugated lectin from Bandeiraea simplicifolia (BS-1 lectin; Sigma-Aldrich). The dual-stained cells, considered to be EPCs, were counted in 12 randomly selected high-power fields under a fluorescence microscope.
Human EPC culture
Human (h)EPCs isolated from human cord blood were purchased from BioChain (BioChain Institute, Inc., Newark, CA) and cultured in hEPC growth medium (BioChain) according to the supplier's protocol. The quality of hEPCs was checked based on the uptake of DiI-Ac-LDL, staining with fluorescein isothiocyanate-conjugated BS-1 lectin and expression of CD34, which was assessed using real-time RT-PCR (data not shown). hEPCs with six to eight passages were used in all experiments. Each individual experiment was repeated at least three times with different cell preparations.
Proliferation assay
hEPCs were cultured for 24 hours in 96-well plates (2500 cells/well) in hEPC growth medium (BioChain) and then incubated with or without human AM (10 29 to 10 27 M) for an additional 48 hours. hEPC proliferation was then assessed +/2 mice after sham operation (Left) or wire injury (Right). The mean of the WT group was assigned a value of 1. Bars depict the mean 6 SE (n = 6 to 10 for each); *P , 0.05, **P , 0.01 vs WT. (c) Representative EVG-stained sections used to evaluate using a cell counting kit-8 (Sigma-Aldrich). As instructed in the manufacturer's protocol, 10 mL of cell counting kit-8 solutions were added to each well of the plate. After incubation for 2.5 hours, the absorbance at 450 nm was measured using a microplate reader.
Tube formation assay
In vitro tube formation assays were performed using Matrigel (BD Biosciences) according to the manufacturer's protocol. hEPCs were seeded onto a layer of Matrigel on plates and incubated for 48 hours in hEPC medium with or without AM (10 27 M).
Statistical analysis
The data are expressed as the mean 6 standard error. Student's t test was used to determine statistically significant differences between the two groups. One-way analysis of variance, followed by Fisher's partial least squares difference, was used to determine statistically significant differences among three or more groups. Values of P , 0.05 were considered statistically significant. 
Results
RAMP2
+/2 mice showed enhanced neointima formation We initially used quantitative real-time PCR to analyze the relative gene expression of the AM-RAMP2 system in the femoral arteries of WT mice with (injury group) or without (sham group) wire-induced vascular injury. The expression of AM was significantly upregulated in the injured arteries of WT mice [ Fig. 1(a) ]. Considering its vasoprotective functions, upregulation of AM might reflect a compensatory response to the vascular injury.
In RAMP2 +/2 mice, expression of RAMP2 was reduced to one-half that in WT mice in both sham-operated [ Fig. 1(b) , left] and wire-injured [ Fig. 1(b) , right] arteries. The expression of CLR was also reduced in RAMP2 We next analyzed the cellular composition of the vascular lesions. Vascular re-endothelialization was assessed by immunostaining for the EC marker CD31, and vascular smooth muscle cell (VSMC) presentation was assessed by immunostaining for a-smooth muscle actin (a-SMA). Consistent with earlier reports (19, 23) , neointimal lesions that formed after wire injury contained large numbers of VSMCs [ Fig. 1(f) ]. Moreover, within the neointima, VSMCs had increased to a greater degree in
+/2 mice than in WT mice [ Fig. 1(g) ]. In contrast, vascular re-endothelialization was significantly decreased in the RAMP2 +/2 mice compared with the WT mice [ Fig. 1(f) and 1(g) ].
Inflammation was enhanced within vascular lesions in RAMP2 +/2 mice Because inflammatory reactions are strongly associated with the progression of atherosclerosis and AM reportedly has anti-inflammatory effects, we assessed the inflammation within the vascular lesions. Immunostaining for F4/80 [ Fig. 2(a) ] revealed that the macrophage numbers in adventitial and neointimal areas were both significantly higher in the RAMP2 +/2 than in the WT mice on day 28 after vascular injury [ Fig. 2(b) ]. Also, real-time PCR analysis revealed that expression of the inflammation-related molecules C-C chemokine receptor type 2 (CCR2), monocyte chemoattractant protein-1 (MCP-1), interleukin (IL)-6, and tumor necrosis factora (TNF-a), were all significantly increased in RAMP2 +/2 mice. Expression of the other inflammation-related molecules, including F4/80, CD68, and transforming growth factor-b1 also tended to be higher in the RAMP2 +/2 than in the WT mice [ Fig. 2(c) ].
Oxidative stress was enhanced within vascular lesions in RAMP2 +/2 mice Vascular inflammation is often accompanied by elevated oxidative stress, and AM stimulating pathways are known to cause an antioxidative effect (6) . We therefore analyzed the oxidative stress level after wire-induced vascular injury. Immunostaining for p67phox, a cytosolic component of a reduced form of NAD phosphate (NADPH) oxidase, was increased to a greater degree in the neointima of RAMP2 +/2 than WT mice [ Fig. 3(a) ].
Real-time PCR analysis also showed that, after wire injury, p67phox expression was significantly increased, and expression of endothelial nitric oxide synthase was slightly reduced in RAMP2 +/2 mice [ Fig. 3(b) ]. In both WT and RAMP2 +/2 arteries, immunostaining revealed the presence of 4HNE, a product of lipid peroxidation, in the adventitia after wire injury. Within the neointimal lesions, however, RAMP2 +/2 arteries stained much more intensely for 4HNE than did the WT arteries [ Fig. 3(c) ].
Effect of vascular EC-specific RAMP2 deletion on neointima formation
To further clarify the involvement of ECs in the worsening of vascular lesions in RAMP2 +/2 mice, we used vascular EC-specific RAMP2 knockout mice (DI-E-RAMP2 2/2 ). After inducing RAMP2 gene deletion for 1 week, the femoral arteries were subjected to wire injury. Subsequent quantitative real-time PCR showed that AM expression was upregulated by wire injury in the control arteries [ Fig. 4(a) ]. Compared with WT arteries, the DI-E-RAMP2 2/2 arteries showed significantly less RAMP2 expression in both sham-operated [ Fig. 4(b) , Left] and wire-injured [ Fig. 4(b) , Right] mice. Although we used EC-specific homozygous knockout mice, the reduction in gene expression was about 50% in the control arteries, perhaps because other vascular cells also express RAMP2. AM expression was significantly unregulated in the DI-E-RAMP2 2/2 arteries, even without wire injury. This suggests that EC-specific RAMP2 deletion evokes the compensatory upregulation of its ligand, AM, indicative of the particular importance of the endothelial AM-RAMP2 system. RAMP3 expression was also significantly upregulated in DI-E-RAMP2
2/2 arteries after wire injury [ Fig. 4(b) , Right], suggesting a complementary interaction between RAMP2 and RAMP3.
Using DI-E-RAMP2 2/2 mice, we investigated the effect of vascular EC-specific RAMP2 deficiency on neointima formation after wire-induced vascular injury. EVG staining revealed marked neointima formation in DI-E-RAMP2 2/2 mice 28 days after injury [ Fig. 4(c) ], and quantitative analysis showed substantial increases in both neointimal areas and I/M ratios in DI-E-RAMP2 Effect of vascular EC-specific RAMP2 deletion on inflammation and oxidative stress When we immunostained arteries for F4/80 to detect the presence of macrophages [ Fig. 5(a) ], we found that the numbers of macrophages in the adventitial and neointimal areas were significantly greater in the DI-E-RAMP2 2/2 than in the control mice 28 days after vascular injury [ Fig. 5(b) ]. Also, the levels of CCR2, MCP-1, IL-6, and TNF-a expression were all significantly increased in the DI-E-RAMP2 2/2 mice [ Fig. 5(c) ].
Immunostaining revealed that the p67phox levels were increased to a greater degree in the neointima of DI-E-RAMP2 2/2 mice than in the WT mice [ Fig. 6(a) ].
This was accompanied by significantly increased expression of p67phox [ Fig. 6(b) ]. In addition, the 4HNE levels were higher in the wire-injured arteries from the DI-E-RAMP2 2/2 mice than in the WT mice, particularly in the neointima [ Fig. 6(c) ].
Effect of RAMP2 in bone marrow-derived cells on neointima formation
It has been suggested that bone marrow cells participate in neointima formation after vascular injury (23) (24) (25) . To assess the effect of RAMP deficiency in bone marrow on the neointima formation seen in RAMP2 +/2 mice, we per- To assess the role of bone marrow-derived cells in the enhanced neointima formation seen in DI-E-RAMP2
2/2 mice, we also evaluated neointima formation after wireinduced injury in BMT control→C57BL/6J
and BMT
mice. We observed that the I/M ratios were significantly increased in BMT DI-E-RAMP22/2→C57BL/6J mice [ Fig. 8(a) and 8(b) ]. In addition, vascular reendothelialization was significantly reduced and neointimal VSMC proliferation was significantly increased in BMT DI-E-RAMP22/2→C57BL/6J mice [ Fig. 8 (c) and
Effects of RAMP2 on EPC proliferation and tube formation We also examined the function of the AM-RAMP2 system in EPCs in vitro. EPCs were initially cultured from bone marrow from control and DI-E-RAMP2 2/2 mice, and DiI-Ac-LDL uptake and staining for BS-1 lectin were analyzed. After 28 days of culture, fewer DiI-Ac-LDL and BS-lection double-positive EPCs were present in the DI-E-RAMP2 2/2 mice than in the control mice [ Fig. 9 (a) and
RT-PCR analysis of blood-derived hEPCs showed expression of AM, RAMP2, and CLR [ Fig. 9(c) ]. WST cell proliferation assays showed that AM administration significantly enhanced hEPC proliferation [ Fig. 9(d) ], and capillary formation assays showed that AM significantly enhanced capillary formation on Matrigel [ Fig. 9 (e) and 9(f)].
Discussion
Atherosclerosis is the leading cause of death worldwide. Narrowing of arterial lumens due to atherosclerotic plaque development or plaque rupture can interrupt normal blood flow, leading to myocardial infarction or stroke. Percutaneous interventions, including balloon angioplasty and stenting, have been used to treat occlusive vascular diseases; however, restenosis remains a major cause of failure of endovascular treatments of atherosclerosis. A precise understanding of the processes underlying atherosclerosis and restenosis will help to identify new biomarkers and targets for novel treatments. We, and others, have suggested that AM could be one such candidate. Although AM is secreted from various organs and tissues, it is mainly produced by vascular ECs (26) and, to a lesser extent, VSMCs (27) . AM initially attracted attention as a vasoactive peptide that induced vasodilation and lowered blood pressure (2). We reported that AM knockout (AM 2/2 ) mice died in utero of vascular structural abnormalities (28) , which indicates that AM is indispensable for proper vascular development. We also observed that blood vessel-specific AM overexpression makes mice resistant to neointimal hyperplasia induced by periarterial cuff placement (15) . AM stimulates EC proliferation and inhibits EC apoptosis (19, 29) and inhibits the migration and proliferation of VSMCs (30) . Consistent with those findings, hypercholesterolemia-induced fatty streak formation was reduced in apolipoprotein E knockout mice crossed with blood vessel-specific AM transgenic mice (15) . Therefore, in addition to its angiogenic function, AM appears to possess vasoprotective actions against various injuries.
Because of its wide range of bioactivity, AM has been attracting attention for its potential clinical application. However, similar to other bioactive endogenous peptides, the clinical applicability of AM has limitations, the most obvious of which is its very short half-life in the blood, which makes its use impractical for treatment of chronic diseases. AM and its family of peptides partially share the same receptor, CLR, with ligand specificity determined by the RAMPs. We showed that RAMP2 2/2 mice exhibit an embryonically lethal phenotype with abnormal vascular development that is essentially identical to the AM 2/2 phenotype (17). This suggests that RAMP2, in particular, could be a therapeutic target through which to manipulate the vascular function of AM. We have therefore worked to clarify the pathophysiological functions of the AM-RAMP2 system by generating and using a series of genetically engineered mice.
In an earlier study, we showed that the angiogenic function of AM is RAMP2-dependent and speculated that RAMP2 also regulates the vasoprotective functions of AM (18) . In the present study, we used RAMP2 +/2 and DI-E-RAMP2 mice. Fifth, bone marrow-derived cells contributed to the enhanced neointima formation observed in the RAMP2 +/2 and DI-E-RAMP2 2/2 mice. Finally, the AM-RAMP2 system enhances EPC proliferation and migration. These data clearly show that the endogenous AM-RAMP2 system plays a key role in maintaining vascular homeostasis and inhibiting the progression of atherosclerosis.
Macrophages and inflammatory mediators stimulate VSMC proliferation and neointimal hyperplasia (31) . In the present study, we found that inflammatory cell invasion and expression of inflammatory molecules, especially IL-6, MCP-1, and CCR2, were increased in both RAMP2
+/2 and DI-E-RAMP2 2/2 mice after vascular injury. Earlier studies showed that the AM-RAMP system . acts to decrease proinflammatory cytokine release (32, 33) . We reported that the expression of inflammatory adhesion molecules is downregulated by AM in vivo (34) . In contrast, we found that congenital EC-specific RAMP2 2/2 mice spontaneously developed vasculitis (18) . In the congenital EC-specific RAMP2 2/2 model, partial detachment of ECs from the basement membrane likely accelerates the attachment, transmigration, and accumulation of inflammatory cells within the vascular wall. In addition, the absence of AM-signaling in RAMP2-deficient ECs upregulated expression of inflammatory adhesion molecules and facilitated the attachment of macrophages (18) . It is widely recognized that an increase in intracellular cyclic adenosine monophosphate within ECs strengthens their barrier function and reduces endothelial permeability, both in vitro and in vivo (35, 36) . We showed that in DI-E-RAMP2
2/2
ECs, downregulation of cyclic adenosine monophosphate production and Rac1 activation reduces cortical actin formation and diminishes endothelial barrier function, facilitating inflammatory cell adhesion to the ECs (18) . Several lines of evidence have suggested that ROS play a crucial role in neointima formation (37, 38) . Inflammation augments oxidative stress and vice versa, and the two coordinately promote vascular lesions, acting in a vicious circle. AM possesses a protective action against cardiovascular damage, possibly through inhibition of ROS production (6) . The major source of ROS is thought to be NADPH oxidase (39) . In the present study, we found that the expression of a NADPH subunit, p67phox, was increased in wire-injured arteries from RAMP2 +/2 and DI-E-RAMP2 2/2 mice. In addition, the levels of 4HNE, a lipid peroxidation product, were increased, predominantly in the neointima of the injured arteries. Thus, increased ROS production might also contribute to the enhanced neointima formation observed in RAMP2 +/2 and DI-E-RAMP2 2/2 mice. This suggests that endothelial RAMP2 might be an effective target through which to regulate ROS and inflammation. Re-endothelialization by bone marrow-derived EPCs is an important determinant affecting neointima formation (21, 40, 41) . Bone marrowderived EPCs are present in the peripheral blood and can be recruited to denuded areas and incorporated into nascent endothelium (42, 43) . EPCs mobilized or transfused systematically are able to home to sites of endothelial denudation, accelerate reendothelialization of injured arteries, and effectively impair proliferation of VSMCs and neointima formation (44) . The role of the AM-RAMP2 system in this process had not been clear. In the present study, therefore, we generated four types of BMT mice (BMT ) and evaluated the neointima formation after wire-induced injury. We observed that bone marrow-derived cells contributed to the enhanced neointima formation in RAMP2 +/2 and DI-E-RAMP2
and that vascular re-endothelialization was suppressed and VSMCs were increased in BMT RAMP2+/2→C57BL/6J
and BMT DI-E-RAMP22/2→C57BL/6J mice. Furthermore, when we cultured primary EPCs from mouse bone marrow and compared the numbers of DiI-Ac-LDL and BS-lectin double-positive EPCs, they were smaller in the DI-E-RAMP2 2/2 mice. Thus, AM-RAMP2 signaling appears to stimulate the proliferation and mobilization of EPCs. Based on its structural homology and similar vasodilatory effects, calcitonin gene-related peptide (CGRP) has been classified as an AM family peptide (2, 45) . We previously reported that neointima formation is enhanced in CGRP 2/2 mice after wire-induced vascular injury but that bone marrow-derived cells did not meaningfully contribute to the enhanced neointima formation observed in CGRP-deficient mice (20) . AM and CGRP act on the same receptor, CLR, but CGRP acts mainly via CLR with RAMP1 (16). We found that EPCs expressed RAMP2 and CLR; RAMP1 expression was very low (data not shown). After vascular injury, endogenous CGRP might contribute to counteract VSMC proliferation but have little effect on EPCs.
In conclusion, RAMP2-deficient mice showed marked neointimal hyperplasia in wire-injured arteries with concomitant suppression of re-endothelialization and increased VSMC proliferation. These results clearly demonstrate that the AM-RAMP2 system has a vasoprotective function after vascular injury, possibly acting in part through stimulation of EPC proliferation. In our preliminary study, we found that RAMP2 overexpression ameliorated vascular lesions (Supplemental Fig. 6 ). We suggest the AM-RAMP2 system could be a therapeutic target for treatment of vascular diseases such as atherosclerosis and restenosis after percutaneous coronary intervention.
